...
首页> 外文期刊>Kaohsiung Journal of Medical Sciences >Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway
【24h】

Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway

机译:HSA-miR-570-3P靶向CD274对三重阴性乳腺癌通过阻断PI3K / AKT / MTOR信号通路的保护作用

获取原文

摘要

To find out the role of hsa-miR-570-3p targeting CD274 in triple negative breast cancer (TNBC) via PI3K/AKT/mTOR signaling pathway. Hsa-miR-570-3p and CD274 expressions in 175 TNBC patients were detected by qRT-PCR and immunohistochemistry respectively. The human TNBC cell lines (MDA-MB-468 and MDA-MB-231) were used to verify the targeting relationship between hsa-miR-570-3p and CD274 via dual-luciferase reporter gene assay. Then, MDA-MB-468 and MDA-MB-231 cells were divided into Blank, miR-NC, miR-570-3p mimics, NC siRNA, CD274 siRNA, and miR-570-3p inhibitors + CD274 siRNA groups. Next, the biological activities of cells were detected by MTT, Cell-Light EdU, Annexin-V-FITC/PI, wound healing and Transwell invasion assays. Western blotting was conducted to detect protein expressions.MiR-570-3p expression was lower in tumor tissues than that in adjacent normal tissues, which was more obvious in CD274-positive TNBC patients, which targeted CD274 in TNBC cell lines. MiR-570-3p inhibited cell proliferation, invasion and migration, but induced cell apoptosis accompanying the upregulation of apoptotic proteins and downregulation of anti-apoptotic protein. CD274 siRNA had the similar results of miR-570-3p mimics, which could be reversed by miR-570-3p inhibitors. Besides, both miR-570-3p mimics and CD274 siRNA blocked PI3K/AKT/mTOR signaling pathway in TNBC cell lines. Hsa-miR-570-3p was downregulated and CD274 was upregulated in TNBC patients. Besides, hsa-miR-570-3p targeted CD274 to inhibit cell proliferation, invasion, migration, and induce cell apoptosis, which may be related to the suppression of PI3K/AKT/mTOR pathway.
机译:通过PI3K / AKT / MTOR信号通路来了解HSA-MIR-570-3P靶向CD274在三阴性乳腺癌(TNBC)中的作用。通过QRT-PCR和免疫组化检测175毫升患者的HSA-MIR-570-3P和CD274表达。人TNBC细胞系(MDA-MB-468和MDA-MB-231)用于验证HSA-miR-570-3P和CD274之间的靶向关系,通过双荧光素酶报告基因测定法。然后,将MDA-MB-468和MDA-MB-231细胞分为坯料,MIR-NC,MIR-570-3P模拟,NC siRNA,CD274 siRNA和MIR-570-3P抑制剂+ CD274 siRNA组。接下来,通过MTT,Cell-Light EDU,annexin-V-Fitc / Pi,伤口愈合和Transwell侵袭测定检测细胞的生物活性。进行Western印迹以检测蛋白质表达。肿瘤组织中的表达比在邻近正常组织中较低,在CD274阳性TNBC患者中更明显,靶向TNBC细胞系CD274。 miR-570-3p抑制细胞增殖,侵袭和迁移,但诱导细胞凋亡伴随凋亡蛋白的上调和抗凋亡蛋白的下调。 CD274 siRNA具有MIR-570-3P模拟的类似结果,可以通过MIR-570-3P抑制剂逆转。此外,MIR-570-3P模拟和CD274 siRNA在TNBC细胞系中封闭了PI3K / AKT / MTOR信号通路。下调HSA-MIR-570-3P,CD274在TNBC患者中上调。此外,HSA-MIR-570-3P靶向CD274,以抑制细胞增殖,侵袭,迁移和诱导细胞凋亡,其可能与抑制PI3K / AKT / MTOR途径有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号